Intracellular cholesterol trafficking is dependent upon NPC2 interaction with Lysobisphosphatidic Acid
- Rutgers University, United States
Abstract
Unesterified cholesterol accumulation in the late endosomal/lysosomal (LE/LY) compartment is the cellular hallmark of Niemann-Pick C (NPC) disease, caused by defects in the genes encoding NPC1 or NPC2. We previously reported the dramatic stimulation of NPC2 cholesterol transport rates to and from model membranes by the LE/LY phospholipid lysobisphosphatidic acid (LBPA). It had been previously shown that enrichment of NPC1-deficient cells with LBPA results in cholesterol clearance. Here we demonstrate that LBPA enrichment in human NPC2-deficient cells, either directly or via its biosynthetic precursor phosphtidylglycerol (PG), is entirely ineffective, indicating an obligate functional interaction between NPC2 and LBPA in cholesterol trafficking. We further demonstrate that NPC2 interacts directly with LBPA and identify the NPC2 hydrophobic knob domain as the site of interaction. Together these studies reveal a heretofore unknown step of intracellular cholesterol trafficking which is critically dependent upon the interaction of LBPA with functional NPC2 protein.
Data availability
All data generated or analysed during this study are included in the manuscript and supporting files
-
1nep, Epididymal secretory protein E1Orientation of Proteins in Membranes (OPM) Database.
-
NPC intracellular cholesterol transporter 2 isoform 2 precursor [Homo sapiens]NCBI Protein Database, NP_006423.1.
-
NPC intracellular cholesterol transporter 2 precursor [Mus musculus]NCBI Protein Database, NP_075898.1.
-
NPC intracellular cholesterol transporter 2 precursor [Bos taurus]NCBI Protein Database, NP_776343.1.
-
epididymal secretory protein E1 [Felis catus]NCBI Protein Database, XP_003987882.1.
-
NPC intracellular cholesterol transporter 2 precursor [Pan troglodytes]NCBI Protein Database, NP_001009075.1.
-
NPC2 [Saccharomyces cerevisiae]NCBI Protein Database, KZV12184.1.
Article and author information
Author details
Funding
Ara Parseghian Medical Research Foundation
- Olga Ilnytska
- Judith Storch
American Heart Association (11PRE7330012)
- Leslie A McCauliff
American Heart Association (18CDA34110230)
- Olga Ilnytska
American Heart Association (14GRNT19990014)
- Judith Storch
National Institutes of Health (GM 1125866)
- Judith Storch
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Copyright
© 2019, McCauliff et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 4,134
- views
-
- 616
- downloads
-
- 56
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Intracellular cholesterol trafficking is dependent upon NPC2 interaction with Lysobisphosphatidic Acid
eLife 8:e50832.
https://doi.org/10.7554/eLife.50832
Further reading
-
- Biochemistry and Chemical Biology
N 6,2’-O-dimethyladenosine (m6Am) is a modified nucleotide located at the first transcribed position in mRNA and snRNA that is essential for diverse physiological processes. m6Am mapping methods assume each gene uses a single start nucleotide. However, gene transcription usually involves multiple start sites, generating numerous 5’ isoforms. Thus, gene-level annotations cannot capture the diversity of m6Am modification in the transcriptome. Here, we describe CROWN-seq, which simultaneously identifies transcription-start nucleotides and quantifies m6Am stoichiometry for each 5’ isoform that initiates with adenosine. Using CROWN-seq, we map the m6Am landscape in nine human cell lines. Our findings reveal that m6Am is nearly always a high stoichiometry modification, with only a small subset of cellular mRNAs showing lower m6Am stoichiometry. We find that m6Am is associated with increased transcript expression and provide evidence that m6Am may be linked to transcription initiation associated with specific promoter sequences and initiation mechanisms. These data suggest a potential new function for m6Am in influencing transcription.
-
- Biochemistry and Chemical Biology
- Structural Biology and Molecular Biophysics
African trypanosomes are the causative agents of neglected tropical diseases affecting both humans and livestock. Disease control is highly challenging due to an increasing number of drug treatment failures. African trypanosomes are extracellular, blood-borne parasites that mainly rely on glycolysis for their energy metabolism within the mammalian host. Trypanosomal glycolytic enzymes are therefore of interest for the development of trypanocidal drugs. Here, we report the serendipitous discovery of a camelid single-domain antibody (sdAb aka Nanobody) that selectively inhibits the enzymatic activity of trypanosomatid (but not host) pyruvate kinases through an allosteric mechanism. By combining enzyme kinetics, biophysics, structural biology, and transgenic parasite survival assays, we provide a proof-of-principle that the sdAb-mediated enzyme inhibition negatively impacts parasite fitness and growth.
